Pharmacoeconomic impact of use of the probiotic Lactobacillus reuteri DSM 17938 for prevention of necrotizing enterocolitis in extremely low-birth-weight infants

• Hoofdauteurs: Dimaguila MAVT (Auteur), Gal P (Auteur), Wilson T (Auteur), Wimmer Jr JE (Auteur), Smith M (Auteur), Carlos RQ (Auteur), Davanzo CC (Auteur), Ransom JL (Auteur)
• Formaat: Boek
• Gepubliceerd in: Dove Medical Press, 2013-04-01T00:00:00Z.
• Onderwerpen: article
• Online toegang: Connect to this object online.

Mary Ann VT Dimaguila,1,2 Peter Gal,1,3,4 Tiffany Wilson,1 John E Wimmer Jr,1,2 McCrae Smith,1,2 Rita Q Carlos,1,2 Christie C Davanzo,1,2 J Laurence Ransom1,2 1Women's Hospital of Greensboro, Cone Health, Greensboro, NC, USA; 2Piedmont Neonatology, Greensboro, NC, USA; 3Eshelman School of Ph...